The Medical Letter on Drugs and Therapeutics
FROM
ISSUE1478
ISSUE1478
September 28, 2015
Flibanserin (Addyi) for Hypoactive Sexual Desire Disorder
Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article. |
Flibanserin (Addyi) for Hypoactive Sexual Desire Disorder
September 28, 2015 (Issue: 1478)
The FDA has approved flibanserin (Addyi – Sprout) for
treatment of premenopausal women with acquired,
generalized hypoactive sexual desire disorder
(HSDD) not caused by another medical or psychiatric
condition, the effects of another drug, or...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.